Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 0 | 3,923 | 8,038 | 3,544 | 7,880 |
| Gross Profit | N/A | 3,923 | 8,038 | 3,544 | 7,880 |
| Operating Expenses | 51,017 | 45,838 | 41,564 | 36,253 | 34,159 |
| Operating Income | -51,017 | -41,915 | -33,526 | -32,709 | -26,279 |
| Other Income | 11,445 | 7,960 | 6,086 | 4,783 | 2,639 |
| Pre-tax Income | -39,572 | -33,955 | -27,440 | -27,926 | -23,640 |
| Net Income Continuous | -39,572 | -33,955 | -27,440 | -27,926 | -23,640 |
| Net Income | $-39,572 | $-33,955 | $-27,440 | $-27,926 | $-23,640 |
| EPS Basic Total Ops | -0.53 | -0.51 | -0.46 | -0.50 | -0.49 |
| EPS Basic Continuous Ops | -0.53 | -0.52 | -0.46 | -0.50 | -0.49 |
| EPS Diluted Total Ops | -0.53 | -0.51 | -0.46 | -0.50 | -0.49 |
| EPS Diluted Continuous Ops | -0.53 | -0.52 | -0.46 | -0.50 | -0.49 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.52 | -0.46 | -0.50 | -0.49 |
| EBITDA(a) | $-56,715 | $-45,162 | $-36,452 | $-34,644 | $-27,248 |